関連する実験動画
Updated: Sep 9, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.8K
地域性喘息ガイドラインがイギリス全土のSABA処方パターンに与える影響: タイムシリーズ分析
Dominic L Sykes1, Michael D Clarkson2, Anita Negbenebor3
1Respiratory Research Group, Hull York Medical School, Hull, UK.
Thorax
|September 2, 2025
まとめ
抗炎症緩和剤 (AIR) を推奨する新しい喘息ガイドラインは,短効ベータアゴニスト (SABA) の処方量を大幅に減らす. 地域的なガイドラインの採用は地元の実践に影響を与え,喘息の管理と患者のアウトカムを改善します.
科学分野:
- 呼吸器医学
- 臨床薬局
- 医療サービス研究
背景:
- 2024年の英国胸部協会のガイドラインは,短効ベータアゴニスト (SABA) の過剰使用を減らすために,抗炎症リリーバー (AIR) の喘息管理を提唱しています.
- 英国 の 地域 の 喘息 ガイドライン は,初期 の 治療 の 勧告 に よっ て 異なっ て い ます.
研究 の 目的:
- SABAの処方パターンに対する地域性喘息ガイドラインの影響を分析する.
- 地元のガイドラインが,国の喘息管理勧告への遵守に影響を与えるかどうかを評価する.
主な方法:
- 34の英語の地域性喘息ガイドラインをSABA-first,吸入用コルチコステロイド (ICS) +SABA,および必要に応じてAIRアプローチに分類する.
- 公開されている処方データの タイムシリーズ分析を中断した.
主要な成果:
- AIRベースのガイドラインの公表により,SABAの処方量が最も大幅に減少しました (毎月0.26%).
- SABA-firstとICS+SABAガイドラインのカテゴリーは,AIRと比較して,より小さく,統計的に有意な減少を示した (p=0. 001とp=0. 004).
結論:
- 地域的な喘息のガイドラインは,地方の処方慣行に影響を及ぼすことが明らかです.
- 地域ガイドラインと国内AIRの勧告を一致させることで 喘息の処方量を最適化し 患者の治療結果を改善できます
関連する概念動画
Antiasthma Drugs: β2-Adrenoceptor Agonists
377
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
377
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-IV: Nursing Management
3.3K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.3K
Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576
Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K

